BridgeBio Pharma and Helsinn Group Announce Strategic Collaboration to Co-Develop and Co-Commercialize BridgeBio’s Novel GPX4 Inhibitor in Multiple Cancer Tumor Types

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy